The new transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses.

Patients who receive more cells get significant benefits. That’s a key lesson emerging from a clinical trial that was reported Nov. 17 at the American Heart Association meeting in Chicago.

Findings pave way for research that focuses on detection and prevention.

New research conducted at the University of Alabama at Birmingham has shown that the common blood pressure drug verapamil completely reverses diabetes in animal models. Now, thanks to a three-year, $2.1 million grant from the JDRF, UAB researchers will begin conducting a potentially groundbreaking clinical trial in 2015 to see if it can do the same in humans.

The joint effort will accelerate the implementation of clinical trials and delivery of stem cell therapies.

In a first step toward future human therapies, researchers at The Saban Research Institute of Children’s Hospital Los Angeles have shown that esophageal tissue can be grown in vivo from both human and mouse cells. The study has been published online in the journal Tissue Engineering, Part A.

Researchers uncovered a new class of lipids in humans that is linked to reduced inflammation and improved blood sugar levels in diabetes.

Improvements were seen within four weeks and generally persisted during treatment duration.

A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for clinicians and law enforcement.

BU team’s device detects virus quickly and on site.